Palisade Bio, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
25.00
|
|
Average Rating
|
4.00
|
|
# Strong Buys
|
1
|
|
# Buys
|
0
|
|
# Holds
|
1
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-4.00
|
-4.00
|
0.00
|
0.00%
|
|
2022-06-30
|
-8.50
|
-6.00
|
2.50
|
29.41%
|
|
2022-03-31
|
-14.00
|
-13.00
|
1.00
|
7.14%
|
|
2021-12-31
|
-11.75
|
4.00
|
15.75
|
134.04%
|
|
2021-09-30
|
-18.00
|
21.00
|
39.00
|
216.67%
|
|
2021-06-30
|
0.00
|
-3.53
|
0.00
|
0.00%
|
|
2021-03-31
|
0.00
|
-4.39
|
0.00
|
0.00%
|
|
2020-12-31
|
0.00
|
-0.25
|
0.00
|
0.00%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-23.00
|
|
2021-12-31
|
17.08
|
|
2020-12-31
|
-13.42
|
|
2019-12-31
|
-13.39
|
|
2018-12-31
|
-3.94
|
|
2017-12-31
|
-95.16
|
|
2016-12-31
|
-190.60
|
|
2015-12-31
|
-2.99
|
|
2014-12-31
|
-19.11
|
|
2013-12-31
|
-67.60
|
|
2012-12-31
|
-3745.71
|
|
2011-12-31
|
-70.20
|
|
2010-12-31
|
-60199.61
|
|
2007-12-31
|
-18415.64
|
|
2006-12-31
|
-4081.15
|